To investigate the short-term effect of combined treatment of traditional Chinese and Western Medicine on patients with advanced non-small cell lung cancer (NSCLC) and its effects on tumor markers, cellular immune function and quality of life.Methods:A total of 94 cases of advanced NSCLC in our hospital from December 2013 to December 2016 were randomly divided into the observation group (47 cases) and the control group (47 cases).The observation group was treated with combination of traditional Chinese medicine and Western medicine, while the control group was treated with GP chemotherapy only.The two groups were treated for 21 d as 1 course, and the curative effect was evaluated after 3 consecutive courses.The short-term effects of the two groups were compared.The changes of serum tumor markers and cellular immune function, the improvement of life quality and the toxic and side effects were observed before and after treatment.Results:The total effective rate in the observation group (63.83%) was higher than that in the control group (40.43%) (P<0.05).CEA, CA199 and NSE decreased after treatment in two groups (observation group:t=16.6497, 22.7240, 16.0180, the control group:t=8.0496, 11.6747, 7.2696, P<0.05); the observation group after treatment, CEA, CA199 and NSE were lower than the control group (t=8.9416, 14.4451, 8.5756, P<0.05).The observation group after treatment, CD3+, CD4+ and CD4+/CD8+ increased (t=11.0410, 7.4541, 7.9279, P<0.05), while the control group after treatment, CD3+, CD4+ and CD4+/CD8+ decreased (t=7.6467, 5.4521, 5.2735, P<0.05); the observation group after treatment CD3+, CD4+ and CD4+/CD8+ was higher than the control group (t=18.3227, 12.0990, 12.1224, P<0.05).The improvement rate of quality of life in observation group (59.57%) was higher than that in control group (36.17%) (P<0.05).The incidence of gastrointestinal reaction, leukocyte reduction, thrombocytopenia and fatigue in the observation group was lower than that in the control group (P<0.05).Conclusion:Combined traditional Chinese and Western medicine in the treatment of advanced NSCLC and can improve the serum tumor markers and cell immune function, improve the quality of life of patients, reduce the adverse reaction, with important research value. |